Immune responses to malignancies
Open Access
- 11 January 2010
- journal article
- review article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 125 (2), S272-S283
- https://doi.org/10.1016/j.jaci.2009.09.045
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck CancerClinical Cancer Research, 2009
- PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+CD25Hi regulatory T cellsInternational Immunology, 2009
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathwayThe Journal of Experimental Medicine, 2009
- Identification of IL-17-producing FOXP3+regulatory T cells in humansProceedings of the National Academy of Sciences of the United States of America, 2009
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patientsProceedings of the National Academy of Sciences, 2006
- Toll-like receptors and innate immunityJournal of Molecular Medicine, 2006
- The power and the promise of DNA methylation markersNature Reviews Cancer, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996